Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Peptide therapy for women is planned and supervised by a licensed provider after an in person evaluation
Regulatory Status AOD-9604 is not FDA-approved for any medical use and is listed by the FDA as a bulk drug substance that may present safety risks. Clinical development was halted after Phase IIb trials failed to meet efficacy endpoints. Summary AOD-9604 is a synthetic analog of the HGH 177191 fragment developed for fat-metabolism research
Versatility: Available in liquids, capsules, or sublingual forms for personalized dosing
It may be helpful for patients with chronic injuries, digestive issues, or other conditions that havent responded well to standard treatments
US$ 25.33
US$ 27.81
US$ 21.60
